trending Market Intelligence /marketintelligence/en/news-insights/trending/lhi5so0rq686ff3ntfiora2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Tonix Pharmaceuticals names board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Tonix Pharmaceuticals names board member

New York-based Tonix Pharmaceuticals Holding Corp. appointed Adeoye Olukotun to its board.

He succeeds Ernest Mario, who stepped down as a director.

Olukotun is CEO of CR Strategies LLC, a clinical research and development consulting firm. His previous roles include CEO of EpiGen Pharmaceuticals Inc. and former vice chairman and CEO of CardioVax Inc.

Tonix Pharmaceuticals has two therapeutic programs focused on post-traumatic stress disorder.